Company profilePharmaceutical#359 of 1,318 in Pakistan✓ No DRAP alerts

SIND MEDICAL STORES

Pharmaceutical company · 48 brands · 49 molecules

Ranked #2 of 17 companies in Vaccine

48 registered products 31 pharmaceutical brands 49 distinct molecules 0 DRAP alerts

Company overview

48
registered products
31
pharmaceutical brands
49
distinct molecules
3
therapeutic classes
0
DRAP alerts

SIND MEDICAL STORES is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 48 product registrations across 49 distinct molecules. Its portfolio is concentrated in Vaccine and Other Bacterial And Viral Vaccines. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SIND

6 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

6
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20266

Top molecules by brand count

Diphtheria, Tetanus And Pertussis Vaccine3 brands

Therapeutic classes

Vaccine · 10Other Bacterial And Viral Vaccines · 3Immune Sera And Immunoglobulins · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official20 products · Rs 330.46 – Rs 25,631.42
DVAGO1 products · Rs 1,834.06 – Rs 1,834.06
Median across source: Rs 2,068.27

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

HAKIMSONS IMPEX (PVT) LTD.10 shared molecules
GSK Pakistan Limited9 shared molecules
Hakimsons Private Limited8 shared molecules
GENE-TECH LABORATORIES6 shared molecules
AMSON6 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SANOFI AVENTIS (PAKISTAN) LTD. holds 75 molecules not in this portfolio
AlfuzosinAmilorideAmiodaroneAspirinAtorvastatinBacillus Clausii
GlaxoSmithKline Pakistan Limited holds 130 molecules not in this portfolio
AcetylcysteineAcyclovirAcyclovir InfAlbendazoleAlbuterolAllopurinol

Get the full profile for SIND

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.